140 related articles for article (PubMed ID: 37164272)
1. Correction of a CADASIL point mutation using adenine base editors in hiPSCs and blood vessel organoids.
Wang J; Zhang L; Wu G; Wu J; Zhou X; Chen X; Niu Y; Jiao Y; Liu Q; Liang P; Shi G; Wu X; Huang J
J Genet Genomics; 2024 Feb; 51(2):197-207. PubMed ID: 37164272
[TBL] [Abstract][Full Text] [Related]
2. CADASIL mutations and shRNA silencing of NOTCH3 affect actin organization in cultured vascular smooth muscle cells.
Tikka S; Ng YP; Di Maio G; Mykkänen K; Siitonen M; Lepikhova T; Pöyhönen M; Viitanen M; Virtanen I; Kalimo H; Baumann M
J Cereb Blood Flow Metab; 2012 Dec; 32(12):2171-80. PubMed ID: 22948298
[TBL] [Abstract][Full Text] [Related]
3. Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
Ruchoux MM; Domenga V; Brulin P; Maciazek J; Limol S; Tournier-Lasserve E; Joutel A
Am J Pathol; 2003 Jan; 162(1):329-42. PubMed ID: 12507916
[TBL] [Abstract][Full Text] [Related]
4. Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells.
Ling C; Liu Z; Song M; Zhang W; Wang S; Liu X; Ma S; Sun S; Fu L; Chu Q; Belmonte JCI; Wang Z; Qu J; Yuan Y; Liu GH
Protein Cell; 2019 Apr; 10(4):249-271. PubMed ID: 30778920
[TBL] [Abstract][Full Text] [Related]
5. Human iPS cell-derived mural cells as an in vitro model of hereditary cerebral small vessel disease.
Yamamoto Y; Kojima K; Taura D; Sone M; Washida K; Egawa N; Kondo T; Minakawa EN; Tsukita K; Enami T; Tomimoto H; Mizuno T; Kalaria RN; Inagaki N; Takahashi R; Harada-Shiba M; Ihara M; Inoue H
Mol Brain; 2020 Mar; 13(1):38. PubMed ID: 32188464
[TBL] [Abstract][Full Text] [Related]
6. NOTCH3 is non-enzymatically fragmented in inherited cerebral small-vessel disease.
Young KZ; Lee SJ; Zhang X; Cartee NMP; Torres M; Keep SG; Gabbireddy SR; Fontana JL; Qi L; Wang MM
J Biol Chem; 2020 Feb; 295(7):1960-1972. PubMed ID: 31901894
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms regulating cerebral hypoperfusion in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
Yan X; Shang J; Wang R; Wang F; Zhang J
J Biomed Res; 2022 Aug; 36(5):353-357. PubMed ID: 36165325
[TBL] [Abstract][Full Text] [Related]
8. Impaired cerebral vasoreactivity in a transgenic mouse model of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy arteriopathy.
Lacombe P; Oligo C; Domenga V; Tournier-Lasserve E; Joutel A
Stroke; 2005 May; 36(5):1053-8. PubMed ID: 15817893
[TBL] [Abstract][Full Text] [Related]
9. [Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)].
Ueda M; Nakaguma R; Ando Y
Rinsho Byori; 2009 Mar; 57(3):242-51. PubMed ID: 19363995
[TBL] [Abstract][Full Text] [Related]
10. A New NOTCH3 Gene Mutation Associated With a CADASIL (Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy) Diagnosis.
Neto D; Cunha M; Gonçalves F; Cotter J
Cureus; 2022 Jul; 14(7):e26495. PubMed ID: 35782589
[TBL] [Abstract][Full Text] [Related]
11. A Novel Heterozygous Variant in Exon 19 of NOTCH3 in a Saudi Family with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy.
Algahtani H; Shirah B; Alharbi SY; Al-Qahtani MH; Abdulkareem AA; Naseer MI
J Stroke Cerebrovasc Dis; 2020 Jul; 29(7):104832. PubMed ID: 32414585
[TBL] [Abstract][Full Text] [Related]
12. [Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)].
Chen YC; Hsiao CT; Soong BW; Lee YC
Acta Neurol Taiwan; 2014 Jun; 23(2):64-74. PubMed ID: 26035923
[TBL] [Abstract][Full Text] [Related]
13. Generation and characterization of the human iPSC line IDISi001-A isolated from blood cells of a CADASIL patient carrying a NOTCH3 mutation.
Fernández-Susavila H; Mora C; Aramburu-Núñez M; Quintas-Rey R; Arias S; Collado M; López-Arias E; Sobrino T; Castillo J; Dell'Era P; Campos F
Stem Cell Res; 2018 Apr; 28():16-20. PubMed ID: 29414412
[TBL] [Abstract][Full Text] [Related]
14. Peripheral arteriopathy caused by Notch3 gain-of-function mutation involves ER and oxidative stress and blunting of NO/sGC/cGMP pathway.
Neves KB; Morris HE; Alves-Lopes R; Muir KW; Moreton F; Delles C; Montezano AC; Touyz RM
Clin Sci (Lond); 2021 Mar; 135(6):753-773. PubMed ID: 33681964
[TBL] [Abstract][Full Text] [Related]
15. ER stress and Rho kinase activation underlie the vasculopathy of CADASIL.
Neves KB; Harvey AP; Moreton F; Montezano AC; Rios FJ; Alves-Lopes R; Nguyen Dinh Cat A; Rocchicciolli P; Delles C; Joutel A; Muir K; Touyz RM
JCI Insight; 2019 Dec; 4(23):. PubMed ID: 31647781
[TBL] [Abstract][Full Text] [Related]
16. Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy with a Novel NOTCH3 Cys323Trp Mutation Presenting Border-Zone Infarcts: A Case Report and Literature Review.
Tojima M; Saito S; Yamamoto Y; Mizuno T; Ihara M; Fukuda H
J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):e128-30. PubMed ID: 27241575
[TBL] [Abstract][Full Text] [Related]
17. New mutations in the Notch3 gene in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL).
Abramycheva N; Stepanova M; Kalashnikova L; Zakharova M; Maximova M; Tanashyan M; Lagoda O; Fedotova E; Klyushnikov S; Konovalov R; Sakharova A; Illarioshkin S
J Neurol Sci; 2015 Feb; 349(1-2):196-201. PubMed ID: 25623805
[TBL] [Abstract][Full Text] [Related]
18. Abnormal recruitment of extracellular matrix proteins by excess Notch3 ECD: a new pathomechanism in CADASIL.
Monet-Leprêtre M; Haddad I; Baron-Menguy C; Fouillot-Panchal M; Riani M; Domenga-Denier V; Dussaule C; Cognat E; Vinh J; Joutel A
Brain; 2013 Jun; 136(Pt 6):1830-45. PubMed ID: 23649698
[TBL] [Abstract][Full Text] [Related]
19. Concentration of non-myocyte proteins in arterial media of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
Lee SJ; Kondepudi A; Young KZ; Zhang X; Cartee NMP; Chen J; Jang KY; Xu G; Borjigin J; Wang MM
PLoS One; 2023; 18(2):e0281094. PubMed ID: 36753487
[TBL] [Abstract][Full Text] [Related]
20. Active immunotherapy reduces NOTCH3 deposition in brain capillaries in a CADASIL mouse model.
Oliveira DV; Coupland KG; Shao W; Jin S; Del Gaudio F; Wang S; Fox R; Rutten JW; Sandin J; Zetterberg H; Lundkvist J; Lesnik Oberstein SA; Lendahl U; Karlström H
EMBO Mol Med; 2023 Feb; 15(2):e16556. PubMed ID: 36524456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
